{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:02:10Z","timestamp":1769508130236,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.peptides.2021.170568","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T19:58:53Z","timestamp":1620849533000},"page":"170568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Apelin improves cardiac function mainly through peripheral vasodilation in a mouse model of dilated cardiomyopathy"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2304-7920","authenticated-orcid":false,"given":"Brahim","family":"El Mathari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Briand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Corbier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Briand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Raffenne-Devillers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pierre","family":"Harnist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Guillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederique","family":"Guilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Janiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.peptides.2021.170568_bib0005","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1-2","key":"10.1016\/j.peptides.2021.170568_bib0010","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0378-1119(93)90495-O","article-title":"A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11","volume":"136","author":"O\u2019Dowd","year":"1993","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.peptides.2021.170568_bib0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/bbrc.2001.6230","article-title":"Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein","volume":"290","author":"Masri","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.peptides.2021.170568_bib0020","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000033522.37861.69","article-title":"Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility","volume":"91","author":"Szokodi","year":"2002","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.peptides.2021.170568_bib0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1139\/bcb-2014-0072","article-title":"The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR","volume":"92","author":"Chapman","year":"2014","journal-title":"Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.peptides.2021.170568_bib0030","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/HYPERTENSIONAHA.109.134619","article-title":"[Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease","volume":"54","author":"Maguire","year":"2009","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.peptides.2021.170568_bib0035","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0006-291X(03)01424-4","article-title":"Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure","volume":"308","author":"Foldes","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.peptides.2021.170568_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2013.07.006","article-title":"Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma","volume":"442","author":"Zhen","year":"2013","journal-title":"Anal. Biochem."},{"issue":"10","key":"10.1016\/j.peptides.2021.170568_bib0045","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.bcp.2007.12.015","article-title":"The apelin-APJ system in heart failure: pathophysiologic relevance and therapeutic potential","volume":"75","author":"Japp","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.peptides.2021.170568_bib0050","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1681\/ASN.2007070816","article-title":"Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli","volume":"19","author":"Azizi","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"28","key":"10.1016\/j.peptides.2021.170568_bib0055","doi-asserted-by":"crossref","first-page":"10464","DOI":"10.1073\/pnas.0403518101","article-title":"Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release","volume":"101","author":"De Mota","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.peptides.2021.170568_bib0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.regpep.2004.10.019","article-title":"Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells","volume":"126","author":"Kleinz","year":"2005","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.peptides.2021.170568_bib0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cardiores.2007.02.002","article-title":"Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice","volume":"74","author":"Zhong","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.peptides.2021.170568_bib0070","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIRCRESAHA.107.158659","article-title":"Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload","volume":"101","author":"Kuba","year":"2007","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.peptides.2021.170568_bib0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cardiores.2004.08.018","article-title":"The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo","volume":"65","author":"Ashley","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.peptides.2021.170568_bib0080","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1021\/acs.jmedchem.7b01353","article-title":"A systematic exploration of macrocyclization in Apelin-13: impact on binding, signaling, stability, and cardiovascular effects","volume":"61","author":"Tran","year":"2018","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.peptides.2021.170568_bib0085","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jacc.2008.06.013","article-title":"Vascular effects of apelin in vivo in man","volume":"52","author":"Japp","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"25","key":"10.1016\/j.peptides.2021.170568_bib0090","doi-asserted-by":"crossref","first-page":"26274","DOI":"10.1074\/jbc.M404149200","article-title":"Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo","volume":"279","author":"Ishida","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.peptides.2021.170568_bib0095","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1161\/CIRCHEARTFAILURE.111.000077","article-title":"Sustained cardiovascular actions of APJ agonism during renin-angiotensin system activation and in patients with heart failure","volume":"6","author":"Barnes","year":"2013","journal-title":"Circ. Heart Fail."},{"issue":"16","key":"10.1016\/j.peptides.2021.170568_bib0100","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCULATIONAHA.109.911339","article-title":"Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure","volume":"121","author":"Japp","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.peptides.2021.170568_bib0105","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/HYPERTENSIONAHA.114.05099","article-title":"Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist","volume":"65","author":"Brame","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.peptides.2021.170568_bib0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1377\/hlthaff.26.1.13","article-title":"Reducing the growing burden of cardiovascular disease in the developing world","volume":"26","author":"Gaziano","year":"2007","journal-title":"Health Aff."},{"issue":"10","key":"10.1016\/j.peptides.2021.170568_bib0115","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"C. American heart association statistics, S. Stroke statistics, heart disease and stroke Statistics-2017 update: a report from the american heart association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.peptides.2021.170568_bib0120","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/GIM.0b013e3181f2481f","article-title":"Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals","volume":"12","author":"Hershberger","year":"2010","journal-title":"Genet. Med."},{"issue":"5364","key":"10.1016\/j.peptides.2021.170568_bib0125","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.280.5364.750","article-title":"Actin mutations in dilated cardiomyopathy, a heritable form of heart failure","volume":"280","author":"Olson","year":"1998","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.peptides.2021.170568_bib0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCRESAHA.110.223834","article-title":"Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history","volume":"108","author":"Seidman","year":"2011","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.peptides.2021.170568_bib0135","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.109.935296","article-title":"Ca2+\/calmodulin-dependent kinase IIdelta causes heart failure by accumulation of p53 in dilated cardiomyopathy","volume":"122","author":"Toko","year":"2010","journal-title":"Circulation"},{"issue":"11 Suppl 1","key":"10.1016\/j.peptides.2021.170568_bib0140","article-title":"Apelin has in vivo inotropic effects on normal and failing hearts","volume":"110","author":"Berry","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.peptides.2021.170568_bib0145","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.bbadis.2016.11.007","article-title":"Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases, Biochimica et biophysica acta","volume":"1863","author":"Zhong","year":"2017","journal-title":"Molecular basis of disease"},{"issue":"9","key":"10.1016\/j.peptides.2021.170568_bib0150","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/nprot.2008.138","article-title":"Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats","volume":"3","author":"Pacher","year":"2008","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.peptides.2021.170568_bib0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/hrt.2004.040337","article-title":"New insights into the pathology of inherited cardiomyopathy","volume":"91","author":"Hughes","year":"2005","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.peptides.2021.170568_bib0160","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 world health Organization\/International society and federation of cardiology task force on the definition and classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.peptides.2021.170568_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093473","article-title":"Apelin increases cardiac contractility via protein kinase Cepsilon- and extracellular signal-regulated kinase-dependent mechanisms","volume":"9","author":"Perjes","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.peptides.2021.170568_bib0170","first-page":"625","article-title":"The impact of apelin-36 on isolated rat hearts as a member of apelin family","volume":"119","author":"Kutlay","year":"2018","journal-title":"Bratisl. Lek. Listy"},{"issue":"3","key":"10.1016\/j.peptides.2021.170568_bib0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","article-title":"Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells","volume":"118","author":"Kleinz","year":"2004","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/j.peptides.2021.170568_bib0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-2999(03)01821-1","article-title":"Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats","volume":"470","author":"Cheng","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2021.170568_bib0185","article-title":"Testosterone and cholesterol vasodilation of rat aorta involves L-type calcium channel inhibition","volume":"2010","author":"Alvarez","year":"2010","journal-title":"Adv. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.peptides.2021.170568_bib0190","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.emboj.7601982","article-title":"Spatial and temporal role of the apelin\/APJ system in the caliber size regulation of blood vessels during angiogenesis","volume":"27","author":"Kidoya","year":"2008","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.peptides.2021.170568_bib0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1253\/circj.CJ-11-0689","article-title":"Cardioprotective effect of apelin-13 on cardiac performance and remodeling in end-stage heart failure","volume":"76","author":"Koguchi","year":"2012","journal-title":"Circ. J."},{"issue":"15","key":"10.1016\/j.peptides.2021.170568_bib0200","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/eurheartj\/ehl123","article-title":"Treatment of chronic heart failure: a comparison between the major guidelines","volume":"27","author":"McMurray","year":"2006","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.peptides.2021.170568_bib0205","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0009-9236(98)90092-3","article-title":"Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study","volume":"63","author":"Elis","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.peptides.2021.170568_bib0210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1067\/mhj.2001.117606","article-title":"Inotropic therapy for heart failure: an evidence-based approach","volume":"142","author":"Felker","year":"2001","journal-title":"Am. Heart J."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121000760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978121000760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:30:27Z","timestamp":1759311027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978121000760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":42,"alternative-id":["S0196978121000760"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170568","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apelin improves cardiac function mainly through peripheral vasodilation in a mouse model of dilated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2021.170568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"170568"}}